Literature DB >> 19371206

Role of NADPH oxidase in atherosclerosis.

Francesco Violi1, Stefania Basili, Carmen Nigro, Pasquale Pignatelli.   

Abstract

Reactive oxidant species (ROS) seem to play a key role in the atherosclerotic process via a series of molecular changes that lead to macrophage infiltration in the endothelium and eventually to plaque formation. ROS are also implicated in arterial dysfunction via inactivation of nitric oxide, a potent vasodilator and antiaggregating molecule produced by the endothelium. Owing to the relevance of endothelial dysfunction and vascular inflammation in the process of human atherosclerosis, a lot of effort has been directed towards discovering the ROS-generating pathways implicated in the ROS upregulation. Amongst the enzymatic pathways, NADPH oxidase is the most important enzyme responsible for ROS formation in human vessels. Experimental and clinical studies suggested a role for this enzyme in initiation and progression of atherosclerotic disease. The purpose of this review is to analyze whether the basic and clinical studies are consistent with this hypothesis and to point out if determination of NADPH oxidase is useful in the setting of the atherosclerosis to predict its progression and clinical complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371206     DOI: 10.2217/14796678.5.1.83

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  20 in total

Review 1.  How metabolism generates signals during innate immunity and inflammation.

Authors:  Anne F McGettrick; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2013-06-24       Impact factor: 5.157

2.  Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice.

Authors:  Xiuping Chen; Hanrui Zhang; Michael A Hill; Cuihua Zhang; Yoonjung Park
Journal:  J Vasc Res       Date:  2016-04-07       Impact factor: 1.934

Review 3.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

Review 4.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 5.  Antioxidant and antiplatelet activity by polyphenol-rich nutrients: focus on extra virgin olive oil and cocoa.

Authors:  Lorenzo Loffredo; Ludovica Perri; Cristina Nocella; Francesco Violi
Journal:  Br J Clin Pharmacol       Date:  2016-04-01       Impact factor: 4.335

6.  Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques.

Authors:  I M Quesada; A Lucero; C Amaya; D N Meijles; M E Cifuentes; P J Pagano; C Castro
Journal:  Atherosclerosis       Date:  2015-08-08       Impact factor: 5.162

7.  Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.

Authors:  Yu-si Cheng; De-zai Dai; Hui Ji; Qi Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

Review 8.  Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?

Authors:  Daniele Pastori; Roberto Carnevale; Pasquale Pignatelli
Journal:  Intern Emerg Med       Date:  2013-09-22       Impact factor: 3.397

Review 9.  Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis.

Authors:  Sina Tavakoli; Reto Asmis
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

10.  Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism.

Authors:  Krysten M Farjo; Rafal A Farjo; Stacey Halsey; Gennadiy Moiseyev; Jian-Xing Ma
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.